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AbstrAct
Introduction There is growing awareness that cancer 
services need to address patients’ well-being as well 
as treating their cancer. We developed systematic 
approaches to (1) monitoring patients’ symptoms including 
depression using a ‘Symptom Monitoring Service’ and 
(2) providing treatment for those with major depression 
using a programme called ‘Depression Care for People 
with Cancer’. Used together, these two programmes 
were found to be highly effective and cost-effective in 
clinical trials. The overall aims of this project are to: (1) 
study the process of introducing these programmes into 
routine clinical care in a large cancer service, (2) identify 
the challenges associated with implementation and how 
these are overcome, (3) determine their effectiveness in a 
routine non-research setting and (4) describe patients’ and 
clinicians’ experience of the programmes.
Methods and analysis This is a mixed-methods 
longitudinal implementation study. We will study the 
process of implementation in three phases (April 2016–
December 2018): ‘Pre-implementation’ (setting up of the 
new programmes), ‘Early Implementation’ (implementation 
of the programmes in a small number of clinics) and 
‘Implementation and Maintenance’ (implementation in 
the majority of clinics). We will use the following methods 
of data collection: (1) contemporaneous logs of the 
implementation process, (2) interviews with healthcare 
professionals and managers, (3) interviews with patients 
and (4) routinely collected clinical data.
Ethics and dissemination The study has been reviewed 
by a joint committee of Oxford University Hospitals 
National Health Service Foundation Trust Research and 
Development Department and the University of Oxford’s 
Clinical Trials and Research Governance Department 
and judged to be service evaluation, not requiring ethics 
committee approval. The findings of this study will guide 
the scaling up implementation of the programmes across 
the UK and will enable us to construct an implementation 
toolkit. We will disseminate our findings in publications and 
at relevant national and international conferences.
IntroductIon
Worldwide, 14.1 million people are diagnosed 
with cancer each year.1 While there have been 
significant advances in anticancer treatments, 
leading to a longer life expectancy for many 
patients, there remains a pressing need to 
also improve patients’ quality of life by better 
management of common cancer-related symp-
toms such as depression, pain and fatigue.2
As part of a research programme, we devel-
oped two clinical programmes which aimed 
to improve the quality of life of patients 
attending cancer services. The first was a 
systematic approach to the assessment of 
symptoms, including depression, called the 
‘Symptom Monitoring Service’ (SMS). The 
second was a system of care for those patients 
with cancer identified as having depression, 
called ‘Depression Care for People with 
Cancer’ (DCPC).3 We prioritised the treat-
ment of depression as its management is 
especially challenging for cancer services. 
Our research found that, used together, SMS 
and DCPC are highly effective and cost-effec-
tive in improving the lives of those patients 
with cancer who suffer from comorbid 
depression.4–8
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Protocol
Strengths and limitations of this study
 ► The mixed-methods design of this study will 
produce a comprehensive summary of the process 
of and barriers and facilitators to implementation.
 ► The implementation of our depression screening and 
treatment programmes was explicitly advocated in 
the 2015 National Health Service Cancer Taskforce 
report, and the findings of this study will inform the 
process of implementation in other centres.
 ► The timeline of the study may be affected by the 
pace of implementation.
 ► The study findings may not be readily generalisable 
to other healthcare systems.
 ► There may be difficulties recruiting patients who do 
not use Symptom Monitoring Service or Depression 
Care for People with Cancer, which may limit our 
understanding of these patients’ views towards the 
services.
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Symptom Monitoring Service
The SMS provides a systematic way of monitoring 
patients’ symptoms, including depression, every time 
they attend the clinic. Approximately 10% of cancer 
outpatients have comorbid major depression.9 Depres-
sion substantially reduces patients’ quality of life and 
ability to cope with anticancer treatments but often goes 
undetected and untreated.9–11 Patients using the SMS are 
assisted to complete brief questionnaires about relevant 
symptoms using touchscreen computers while waiting for 
their appointment. These questionnaires include symp-
toms relevant to all clinics (eg, depressive symptoms and 
pain) as well as symptoms relevant to specific clinics (eg, 
coughing up blood in the lung cancer clinic). The results 
of these questionnaires are available to the patient’s clini-
cian (eg, oncologist or cancer nurse specialist) before 
the appointment. The clinician can use this information 
to: (1) identify patients with severe symptoms; (2) detect 
changes in patients’ symptoms over time; (3) determine 
which symptoms require further assessment; (4) ensure 
that patients receive appropriate treatment for their 
symptoms. To identify patients with major depression 
(the diagnostic term for depression which requires treat-
ment), those with a high score on the relevant symptom 
questionnaire are offered a telephone-delivered diag-
nostic interview.12
These semistructured clinical interviews are based on the 
major depression section of the Structured Clinical Inter-
view for the Diagnostic and Statistical Manual of Mental 
Disorders.13 Telephone interviews are used because these 
are more feasible than attempting to achieve interviews 
in the clinic, are convenient and acceptable to patients 
and have been found to have good agreement with face-
to-face interviews.14 15 The SMS is delivered by a team of 
symptom monitoring assistants, trained and supervised 
by consultation-liaison psychiatrists; further details are 
given in our previous publication.16 Patients identified as 
having a diagnosis of major depression are offered partic-
ipation in the linked DCPC treatment programme.
depression care for People with cancer
DCPC is a manualised, systematic, multicomponent, 
team-delivered treatment programme for patients with 
cancer and major depression that is based on the collab-
orative care model.3 17 The treatment team comprises 
care managers (specially trained cancer nurses) and 
consultation-liaison psychiatrists who work closely with 
the patient’s general practitioner (GP) and oncologist. 
The care managers establish a therapeutic relationship 
with the patient, provide education about depression, 
deliver brief evidence-based psychological treatments 
(behavioural activation and problem solving therapy) 
and systematically monitor the patient’s progress.18 19 The 
psychiatrists supervise treatment with the aim of achieving 
and then maintaining specified treatment targets, advise 
GPs and oncologists on the prescription of antidepres-
sant medication and also provide direct consultations to 
those patients who are not improving.
the process of implementing a new service
Implementation of these systems has been explicitly advo-
cated in the 2015 National Health Service (NHS) Cancer 
Taskforce report.20 However, it is well known that the 
translation from delivering services as part of research 
programmes to delivering them in routine clinical prac-
tice can be difficult and may lead to innovative services 
failing to realise their promise.21
Aim
Our aim is to study the implementation of SMS and DCPC 
into the routine clinical care provided by a large cancer 
service in Oxford, UK, with a view to learning how best 
to facilitate the introduction of these programmes into 
other cancer services. We will: (1) describe the process 
of implementation, (2) identify the challenges in imple-
mentation and how these are overcome, (3) determine 
the programmes’ effectiveness in clinical practice and 
(4) describe patients’ and clinicians’ experience of them. 
Detailed aims are described in table 1.
MethodS And AnAlySIS
Study design
We will use a mixed-methods design to longitudinally 
study the process of introducing SMS and DCPC into the 
Oxford Cancer Centre. The Oxford Cancer Centre is a 
large cancer service, which is part of Oxford University 
Hospitals NHS Foundation Trust. It receives approxi-
mately 19 000 new referrals per year, has 58 consultant 
oncologists and comprises inpatient wards, operating 
theatres, a day hospital and outpatient departments.
The study will focus on three phases: ‘Pre-implemen-
tation’ (setting up of the new programmes), ‘Early 
Implementation’ (implementation in a small number 
of clinics) and ‘Implementation and Maintenance’ 
(implementation in the majority of clinics). Our 
specific aims are described in detail in table 1. In the 
pre-implementation phase, we will study the process of 
setting up the new programmes, the challenges encoun-
tered during set-up and the ways these are addressed. 
In the early implementation and implementation and 
maintenance phases, we will describe the challenges 
encountered and how they are addressed, the effec-
tiveness of the programmes in clinical practice and 
the experiences of both the patients who have access 
to SMS and DCPC and of the healthcare professionals 
involved in them.
We will use the following methods of data collec-
tion: (1) contemporaneous logs of the implementation 
process, (2) interviews with healthcare professionals and 
managers, (3) interviews with patients and (4) routine 
clinical data. Data collection in the Early Implementation 
and Implementation and Maintenance phases will be 
guided by the RE-AIM (Reach, Effectiveness, Adoption, 
Implementation, Maintenance) framework.22 23
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Preimplementation phase
Contemporaneous log
A contemporaneous events log will be used by the study 
team to record any activities and events related to setting 
up the new programmes in the cancer service and will 
include regular correspondence from staff involved in 
setting up the service.24 Sample activities and events to be 
included are recruitment and training events, and meet-
ings with clinical managers and information technology 
experts. Each entry to the log will include information on 
the date of the action or event, the people involved and 
its effects on the delivery of the programmes.
Interviews with healthcare professionals and managers
We will recruit and interview 10–15 healthcare profes-
sionals and managers who are involved in setting up SMS 
and DCPC in the cancer service. Based on similar studies, 
we anticipate this sample size will be sufficient to reach 
data saturation.25 Interviews will take approximately 
30 min, will be audio-recorded and transcribed verbatim 
and will be conducted at the participants’ preferred loca-
tion or by telephone. Interviews will be semistructured 
following a topic guide which will focus on participants’ 
views of the process of setting up the programmes. They 
will be conducted by a trained member of the study team 
with previous experience of interviewing healthcare 
professionals.
Analysis
A timeline of events that occur during set-up will be drawn 
using the contemporaneous log. Data from the log will 
then be analysed using content analysis, which will involve 
data familiarisation and coding. Codes will be developed 
focusing on the process of setting up the programmes, 
the associated challenges and the ways that these are 
addressed. The codes developed from the contempora-
neous log will be applied to the transcripts of interviews 
with healthcare professionals and managers and will be 
further refined. These codes will be then sorted into 
subcategories and categories.
early implementation and implementation and maintenance 
phases
Contemporaneous log
We will record and use data in a contemporaneous events 
log in the same away as in the pre-implementation phase. 
This will allow us to describe the time taken for each step 
of implementation.
Interviews with healthcare professionals and managers
We will recruit 20–30 healthcare professionals and 
managers during the Early Implementation and Imple-
mentation and Maintenance phases. These will include 
psychiatrists and care managers involved in the delivery 
of the SMS and DCPC, and oncologists, cancer nurse 
specialists and GPs who make up the wider collaborative 
care team. Based on similar studies, we anticipate this 
sample size will be sufficient to reach data saturation.25 
Semistructured Interviews will take approximately 30 min, 
will be audio-recorded and transcribed verbatim and will 
be conducted at the participant’s preferred location or 
by telephone. Interviews will be conducted by a trained 
member of the study team with previous experience of 
interviewing healthcare professionals. The interview 
topic guide will focus on the participants’ experience of 
the new programmes.
Interviews with patients
We will recruit and interview 40–60 patients during the 
Early Implementation and Implementation and Main-
tenance phases. These will include patients who do not 
use the first stage of the SMS service (n=10–15), who use 
the SMS service (n=10–15), who do not use the DCPC 
treatment programme (n=10–15) and who use the 
DCPC treatment programme (n=10–15). We will exclude 
patients who are unable to provide informed consent to 
participate or do not understand and speak English suffi-
ciently to participate in a qualitative interview. Interviews 
will take between 30 and 60 min, will be audio-recorded 
and transcribed verbatim and will be conducted at the 
participant’s preferred location or by telephone. Inter-
views will be conducted by a trained member of the study 
team with previous experience of interviewing patients 
with cancer. The interview topic guide will focus on 
patients’ understanding and views of the SMS and DCPC.
Routine clinical data
We will obtain the following data from the cancer 
centre: the number and characteristics of clinics with 
and without the new programmes over time, the propor-
tion of patients who do and do not receive each part of 
the programmes and their characteristics, the staff and 
other resources required and costs of delivering SMS 
and DCPC, adherence to the SMS and DCPC manuals 
including diagnostic accuracy, outcomes of patients who 
receive the programmes and description of any relevant 
adverse clinical events.
Analysis
Data recorded in the contemporaneous log related to 
the introduction of SMS and DCPC in clinics will be used 
to draw a timeline across the Early Implementation and 
Implementation and Maintenance phases. Then, data 
from the contemporaneous log will be analysed using 
content analysis, which will involve data familiarisation 
and coding. Codes will be developed focusing on: the 
process of implementation, challenges associated with 
day-to-day running of SMS and DCPC, challenges asso-
ciated with implementation and long-term maintenance, 
challenges associated with delivering SMS and DCPC as 
intended and the ways that these challenges are addressed. 
Codes developed from the contemporaneous log will be 
applied to selected relevant excerpts from the transcripts 
of qualitative interviews with healthcare professionals. 
These codes will be further refined and then sorted into 
subcategories and categories.
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Data generated from the qualitative interviews with 
patients and with healthcare professionals involved in 
SMS and DCPC will be analysed using thematic analysis 
to describe their experiences.26 The stages of the analysis 
will include data familiarisation, coding and development 
of themes. Data collection and analysis will take place 
simultaneously to allow the exploration of themes from 
the initial interviews in subsequent ones. In order to mini-
mise subjective biases, the coding will be discussed among 
members of the study team.
We will analyse the routine clinical data using descrip-
tive statistics in order to summarise: the effectiveness of 
DCPC over time (including benchmarking against the 
patient outcomes in our clinical trials), the proportion 
and characteristics of the target population who have 
access to and who use SMS and DCPC over time, the 
fidelity of the delivery of SMS and DCPC, adherence 
of patients with each component of the DCPC and the 
cost of the new services. We will use data from qualitative 
interviews to understand these results, for example, how 
challenges in the adherence to the protocol may influ-
ence the effectiveness of the service.
ethics and dissemination
The study has been reviewed by a joint committee of 
Oxford University Hospitals NHS Foundation Trust 
Research and Development Department and the Univer-
sity of Oxford’s Clinical Trials and Research Governance 
Department and has been judged to be service evalua-
tion, not requiring ethics committee approval. The study 
has been registered with the Oxford University Hospitals 
NHS Foundation Trust service evaluation and clinical 
audit team. The results of the study will be disseminated 
via presentations at local, national and international 
conferences, peer-reviewed journals and workshops with 
stakeholders. The implementation of SMS and DCPC in 
UK cancer centres is explicitly advocated in the 2015 NHS 
Cancer Taskforce report.10 The findings from the study 
will be crucial for scaling up implementation and will 
form part of a toolkit for doing this.
dIScuSSIon
Our overall aim is to study the process of setting up and 
introducing two new linked clinical programmes (SMS 
and DCPC) in a large UK cancer service, to describe the 
challenges associated with their implementation and how 
these are addressed, to measure their effectiveness in 
clinical practice and to describe patients’ and clinicians’ 
experience of using them. While these programmes have 
already been successfully implemented in the context of 
a large research programme and have been found to be 
effective and cost-effective in clinical trials, this is the first 
time that they have been implemented in a non-research 
setting.
The Early Implementation and Implementation and 
Maintenance phases of our study will use the RE-AIM 
framework to guide data collection, analysis and reporting 
of findings. The authors of this framework have recently 
highlighted the importance of collecting data in relation 
to all components of RE-AIM framework and especially 
qualitative data about patients not using the service.23 
Our study follows both of these recommendations.
We anticipate a number of challenges in conducting this 
research. First, the timeline of the study will be affected 
by the pace of implementation. We have divided the 
study into three phases to minimise delays to data collec-
tion. Second, there may be difficulties in recruiting busy 
healthcare professionals and managers for interviews. We 
have mitigated this risk by working closely with healthcare 
professionals and managers to identify research questions 
which are of interest to them.
Thirdly, this study involves multiple methods of data 
collection. We will make sure that we integrate qualitative 
and quantitative findings to further our understanding 
of the challenges associated with the implementation of 
the clinical programmes. Finally, we will also make sure 
that the research team works sufficiently close with the 
implementation team to be able to gather data while 
remaining independent enough to portray the problems 
accurately.27
This study will provide us with robust new knowl-
edge, essential for service planning, about the process 
of implementing these two linked programmes and the 
challenges to implementation success. We will also find 
out what patients and clinicians think of SMS and DCPC 
and how they can be further improved. The findings 
of this study will be crucial for scaling up implementa-
tion of the programmes across the UK and will enable 
us to construct a toolkit for this purpose. More widely, 
the study findings will further our understanding of the 
mechanisms involved in implementing new systems of 
care within an established clinical service.
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